Atlas Trials

Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma

Clinical trial NCT04583020 · UNKNOWN

Trial details

NCT number
NCT04583020
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2020-11-12
Primary completion
2023-12-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.